UGT1A9 antibody (N-Term)
Quick Overview for UGT1A9 antibody (N-Term) (ABIN636089)
Target
See all UGT1A9 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- UGT1 A9 antibody was raised against the N terminal of µgT1 9
-
Purification
- Affinity purified
-
Immunogen
- UGT1 A9 antibody was raised using the N terminal of µgT1 9 corresponding to a region with amino acids LLMGSYNDIFDLFFSNCRSLFKDKKLVEYLKESSFDAVFLDPFDNCGLIV
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
UGT1A9 Blocking Peptide, (ABIN5616901), is also available for use as a blocking control in assays to test for specificity of this µgT1A9 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of µgT0 9 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- UGT1A9 (UDP Glucuronosyltransferase 1 Family, Polypeptide A9 (UGT1A9))
-
Alternative Name
- UGT1A9
-
Background
- UGT1A9 is a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. UGT1A9 is active on phenols.
-
Molecular Weight
- 57 kDa (MW of target protein)
-
Pathways
- Steroid Hormone Biosynthesis, Regulation of Lipid Metabolism by PPARalpha
Target
-